ID   UM-HACC-14
AC   CVCL_E7RZ
SY   University of Michigan-Human Adenoid Cystic Carcinoma-14
RX   PubMed=38971694;
CC   Population: Indian.
CC   Doubling time: 24 hours (PubMed=38971694).
CC   Derived from site: Metastatic; Eye lid; UBERON=UBERON_0001711.
ST   Source(s): PubMed=38971694
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 12,15
ST   D21S11: 30,31.2
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   D8S1179: 12,14
ST   FGA: 19,20
ST   Penta D: 11,12
ST   Penta E: 7,14
ST   TH01: 9.3
ST   TPOX: 12,13
ST   vWA: 17,18
DI   NCIt; C8026; Salivary gland adenoid cystic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
RX   PubMed=38971694; DOI=10.1016/j.oooo.2024.06.005; PMCID=PMC11827064;
RA   Warner K.A., Herzog A.E., Sahara S., Nor F., Castilho R.M., Demirci H.,
RA   Chepeha D.B., Polverini P.J., Nor J.E.;
RT   "Establishment and characterization of cMYB-expressing human salivary
RT   adenoid cystic carcinoma cell lines (UM-HACC-14, UM-HACC-6) and
RT   matching patient-derived xenograft model (UM-PDX-HACC-14).";
RL   Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 138:516-531(2024).
//